Blog - A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa's private sector but not yet in public clinics. The country's advisory group on ...

London: GSK plc has announced that the US Food and Drug Administration (FDA) has accepted for review an application to extend ...

GSK plc (GSK) said on Monday that its application for extending the use of its respiratory syncytial virus (RSV) vaccine ...

Andrea Sanders and William Bonfanti are two dedicated employees working closely with respiratory patients at the Montreal ...

GSK said the US Food and Drug Administration has accepted an application for review to extend the indication of its Arexvy respiratory syncytial virus vaccine to adults aged 18-49 who are at increased ...

At 21 months old, Olivia is bright, bubbly, and full of joy. But instead of running around like other toddlers, she’s spent ...

After her newborn son Ari stopped breathing, Lee Adams from Epsom raised £530 for The Sick Children’s Trust by walking 50 ...

Child mortality has been halved in the last 25 years. Building on this progress, new innovations in immunization are working ...

You’re not imagining it, flu cases are on the rise this season, as vaccination levels decline and COVID-style social ...

Merck is closing in on a $10bn (€8.5bn) deal to acquire respiratory drugmaker Verona Pharma, the Financial Times reported.